# Bevacizumab for Primary Pterygium Treatment

> **NCT01686529** · PHASE1 · COMPLETED · sponsor: **Instituto de Oftalmología Fundación Conde de Valenciana** · enrollment: 49 (actual)

## Conditions studied

- Pterygium

## Interventions

- **PROCEDURE:** Autoconjunctival grafting
- **DRUG:** Subconjuntival bevacizumab injection

## Key facts

- **NCT ID:** NCT01686529
- **Lead sponsor:** Instituto de Oftalmología Fundación Conde de Valenciana
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-03
- **Primary completion:** 2011-02
- **Final completion:** 2012-02
- **Target enrollment:** 49 (ACTUAL)
- **Last updated:** 2013-12-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01686529

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01686529, "Bevacizumab for Primary Pterygium Treatment". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01686529. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*